Effects of Liposomal Bupivacaine for Acute Pain in Hip and Femur Fractures
Status:
Terminated
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
This is an investigator-initiated, single-center, randomized, patient blinded, controlled
trial. The purpose of this study is to compare the effect of a fascia iliaca compartment
block (FICB) using 0.2% ropivacaine vs. liposomal bupivacaine in patients with femur and/or
hip fractures admitted to the University of California Davis Medical Center (UCDMC). The
primary endpoint will be the total opioid requirements during the 96 hour randomization
period with secondary endpoints including total daily opioid requirements for days 1-4,
duration of effect and objective pain scores using the numeric rating scale (NRS) during
their hospital stay.